Opinion: Public Data, Private Concerns

Research participants aren’t always clear on open data policies when consenting to studies.

Written byViviane Callier
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

FLICKR, BOB MICALEvery week, hundreds of papers that involve human participants in biology, medicine, psychology, sociology, political science, and anthropology research are published. And an increasing proportion of these appear in journals with open data policies. Such policies require researchers to make their complete data freely available. These requirements benefit scientific research: access to the complete raw data enables other researchers to replicate findings and leverage existing resources. But when research involves people, open data policies can bungle the participant consent process because there is no commonly used mechanism to balance participants’ confidentiality with the benefit to science.

Discussions about open data policies have thus far focused primarily on the needs and concerns of members of the scientific community. The discussion has yet to include the needs and concerns of participants whose data are being openly shared. And as more journals adopt open-data policies, researchers lose control of their participants’ data upon publication. It could be ethically problematic for research participants’ potentially sensitive information to be made freely available, not only to other researchers but also to third parties. Open data policies might, therefore, affect participants’ willingness to participate in research.

To test this notion, psychology researchers Jorden Cummings and Jessica Zagrodney from the University of Saskatchewan and medical systems engineer Eugene Day from the Children’s Hospital of Philadelphia designed an experiment in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Viviane was a Churchill Scholar at the University of Cambridge, where she studied early tetrapods. Her PhD at Duke University focused on the role of oxygen in insect body size regulation. After a postdoctoral fellowship at Arizona State University, she became a science writer for federal agencies in the Washington, DC area. Now, she freelances from San Antonio, Texas.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies